About Us

What’s In A Name

The Kestrel is a hunting bird that hovers at a low altitude to spot its prey before diving in for the catch. The word Biologic is the simple combination of biology and logic. As a company, Kestrel Biologic maintains a low level view to help spot issues before they become problems. Our approach to challenges is to utilize logic to provide appropriate and human solutions for our clients.

Industry Background

Through decades of industry experience, the Kestrel Biologic team knows the challenges of effective risk based monitoring and has identified the need for an improved way to capture risk planning in a dynamic and easy to update system that drives and links oversight and monitoring activities throughout the different phases of clinical trials. With the development of the iQROS™ software, Kestrel has created an effective solution that expands beyond the traditional clinical trial model and can save both time and money in the process. Learn More

“The current clinical trial model is flawed at best. Pharma is investing increasing amounts of time and money into clinical research, yet failures keep coming with an abysmal success ratio of 1 in 10 programs that enter trials. Pharma companies are spending billions of dollars for each successful program. And the spiraling costs come at a time when technology, particularly mobile, is supposed to be making life more efficient”.

Fierce Biotech, March 2013

Lorne Cheeseman

Company Leader Extraordinaire

Through his extensive background in managing and training clinical teams, monitoring clinical trial sites, developing SOPs and quality systems, and international clinical research expertise, Lorne knows the clinical industry. He has held national and international leadership positions in companies such as Pfizer, Quintiles, Gilead Pharmaceuticals and Allergan that provided a solid base for his role at Kestrel.

Lorne took on the role as CEO at Kestrel Biology in 2013. He has taken the company to the next level and is determined to make iQROS™ a household name in the pharmaceutical industry.

With over thirty years of experience in the information technology field, Gordon has experienced many technological revolutions and been a part of organizations ranging from large multinational corporations to small non-profit companies. This range of experience has given him a rare perspective on the art of developing software that meets the initial needs of the stakeholders as well as the importance of developing the infrastructure and process required to continually meet those needs over time, no matter the size of the project or company.

Gordon joined Kestrel Biologic as IT Director in the fall of 2014 and has led the development of the present iQROS™ application.

Gordon Gilbertson

Technology Guru

Lorne Cheeseman

Company Leader Extraordinaire

Through his extensive background in managing and training clinical teams, monitoring clinical trial sites, developing SOPs and quality systems, and international clinical research expertise, Lorne knows the clinical industry. He has held national and international leadership positions in companies such as Pfizer, Quintiles, Gilead Pharmaceuticals and Allergan that provided a solid base for his role at Kestrel.

Lorne took on the role as CEO at Kestrel Biology in 2013. He has taken the company to the next level and is determined to make iQROS™ a household name in the pharmaceutical industry.

Gordon Gilbertson

Technology Guru

With over thirty years of experience in the information technology field, Gordon has experienced many technological revolutions and been a part of organizations ranging from large multinational corporations to small non-profit companies. This range of experience has given him a rare perspective on the art of developing software that meets the initial needs of the stakeholders as well as the importance of developing the infrastructure and process required to continually meet those needs over time, no matter the size of the project or company.

Gordon joined Kestrel Biologic as IT Director in the fall of 2014 and has led the development of the present iQROS™ application.

Client Testimonial

“…iQROS™ and the highly knowledgeable staff at Kestrel was the perfect solution and far exceeded my expectations. After my experience with them, my expectations for their type of service are now much higher…. Their combined experience with using this risk-based methodology in the pharmaceutical industry is very powerful. Currently, we are pursuing their engagement on other clinical projects within our organization.”

Kathy Goin, Endo Pharmaceuticals